Ischaemic, compressive, toxic and hereditary optic neuropathies
After optic neuritis, the optic nerve can fail because its blood supply is cut off, because something presses on it, because a drug or deficiency poisons it, or because of an inherited fault in its mitochondria. This lesson teaches how to tell these apart, with most weight on giant cell arteritis, where treatment within hours saves the second eye.
Recognising an optic neuropathy and sorting by tempo
Every optic neuropathy shares the same signs: reduced acuity, reduced colour vision, a relative afferent pupillary defect if one side is worse, a field defect, and a disc that is either swollen now or pale later. The cause is found from the tempo and the company it keeps. Sudden painless loss in an older person is ischaemic. Loss over days with pain on eye movement in a young adult is optic neuritis, covered in the previous lesson. Slow progressive loss in one eye is compressive until a scan says otherwise. Slow, symmetrical loss in both eyes with central scotomas is toxic, nutritional or hereditary.
The optic nerve head is supplied by the short posterior ciliary arteries, small branches of the ophthalmic artery, not by the central retinal artery. Anterior ischaemic optic neuropathy (AION) is an infarct of the nerve head in this territory. Because the nerve head swells when it infarcts, the disc is always swollen at the start. There are two forms: non-arteritic, which is common, and arteritic, which is caused by giant cell arteritis and accounts for only 5 to 10% of cases but is the emergency.
3D atlasThe short posterior ciliary arteries supply the optic nerve head. Their occlusion causes anterior ischaemic optic neuropathy.Non-arteritic anterior ischaemic optic neuropathy
Non-arteritic AION (NAION) typically affects people over 50 with hypertension or diabetes. In the main treatment trial of NAION, 47% of patients had hypertension and 24% had diabetes. Obstructive sleep apnoea is another association. The patient notices painless loss of vision in one eye, often on waking, which has led to the theory that a fall in blood pressure during sleep tips a vulnerable nerve head into ischaemia.
The anatomical risk factor is a small, crowded disc with little or no cup, called the disc at risk. Look for it in the other eye, where the cup to disc ratio is typically under 0.3. The idea is a compartment syndrome: axons swell in a tight scleral canal, compress their own capillaries and swell further.
- Acuity is variable and often fairly good. No perception of light is very rare and should suggest arteritis.
- The field defect is classically altitudinal: loss of the upper or lower half of the field with a border on the horizontal midline. Inferior loss is commonest.
- The disc swelling is pink (hyperaemic), often affects one sector, and has splinter haemorrhages at its edge.
- Inflammatory markers are normal and there are no systemic symptoms.
No treatment has been shown to work. Management is to exclude giant cell arteritis, treat vascular risk factors and sleep apnoea, and warn the patient that the other eye can be affected later. A link with phosphodiesterase-5 inhibitors such as sildenafil has been proposed but a causal relationship is not established.
Giant cell arteritis and arteritic AION
Giant cell arteritis (GCA) is a granulomatous inflammation of medium and large arteries in people aged 50 and over. The inflamed wall thickens until the lumen closes. When the posterior ciliary arteries close, the result is arteritic AION: sudden, profound loss of vision with a swollen disc that is characteristically pale (chalky white). The same process can occlude a cilioretinal artery or the central retinal artery, and can cause double vision from ischaemia of the eye muscles or their nerves. Fleeting loss of vision (amaurosis fugax) in the days before is a warning that an infarct is imminent.
NICE CKS advises suspecting GCA in anyone aged 50 or over with one or more of the following.
- New headache, usually temporal. It is present in about two thirds.
- A tender, thickened or pulseless temporal artery.
- Scalp tenderness, for example when brushing the hair.
- Jaw or tongue claudication: pain in the chewing muscles after a few minutes of chewing. It signals a high risk of ischaemic complications.
- Visual symptoms: loss of vision, a field defect or diplopia.
- Fever, sweats, weight loss and fatigue.
- Polymyalgia rheumatica: pain and stiffness of the shoulder and hip girdles.
Blood is taken for ESR, CRP and a full blood count. The ESR is often above 50 mm/hour, the CRP is raised and the platelet count is often high. A normal ESR does not exclude the disease, but it is unusual for both ESR and CRP to be normal: this happens in fewer than 3% of cases. Some patients have no headache at all and present only with visual loss and raised markers, so the markers are checked in every patient over 50 with AION.
Treatment follows the British Society for Rheumatology (BSR) guideline, as set out by NICE CKS. High-dose glucocorticoid is started immediately on strong clinical suspicion, without waiting for a biopsy.
- No visual symptoms: oral prednisolone 40 to 60 mg daily, at the upper end if there is jaw or tongue claudication, with specialist review within 3 working days.
- Visual loss or diplopia: same-day ophthalmology assessment. Intravenous methylprednisolone is often given for up to 3 days before oral prednisolone. If it cannot be given, oral prednisolone 60 to 100 mg daily is used for up to 3 days.
- Every patient has a confirmatory test: temporal artery ultrasound, temporal artery biopsy, or both. Ultrasound shows a dark halo of wall oedema around the lumen. Biopsy shows inflammation of the wall with giant cells and fragmentation of the internal elastic lamina.
- Steroid is tapered slowly over many months, with bone and gastric protection. Methotrexate or tocilizumab may be added by a specialist for relapse or steroid toxicity.
| Arteritic (GCA) | Non-arteritic | |
|---|---|---|
| Share of AION | 5 to 10% | The great majority |
| Age | 50 and over, usually much older | Over 50 |
| Systemic symptoms | Headache, jaw claudication, scalp tenderness, polymyalgia | None |
| Preceding amaurosis fugax | Common | Very unusual |
| Visual loss | Severe, may be no perception of light | Mild to moderate |
| Disc swelling | Pale, chalky white | Pink, often sectoral |
| Fellow disc | Normal cup | Small crowded disc at risk |
| ESR, CRP, platelets | Raised | Normal |
| Treatment | Immediate high-dose steroid | None proven |
Compressive optic neuropathy
A mass pressing on the optic nerve causes slow, progressive, painless loss of vision in one eye, with poor colour vision, a relative afferent pupillary defect and a central or other field defect. The disc may look normal at first and later turns pale. Compression inside the orbit can also swell the disc and push the eye forward. Causes include optic nerve sheath meningioma, optic nerve glioma, pituitary and other tumours around the sella, aneurysms, and the enlarged muscles of thyroid eye disease at the orbital apex.
Optociliary shunt vessels are a classic sign of chronic compression, particularly by an optic nerve sheath meningioma. They are collateral veins on the disc that divert retinal venous blood into the choroidal circulation when the central retinal vein is slowly obstructed. The practical rule is that unexplained, progressive visual loss or unexplained optic atrophy requires MRI of the orbits and brain, because compression is treatable and vision can recover when the pressure is removed.
Toxic and nutritional optic neuropathies
These conditions look alike: bilateral, symmetrical, painless loss of central vision that develops over weeks, with early loss of colour vision and central or caecocentral scotomas (a caecocentral scotoma joins fixation to the blind spot). The discs are normal or slightly swollen at first and later show temporal pallor. The common mechanism is failure of mitochondrial energy production. The fibres that suffer first are the small, thinly myelinated fibres of the papillomacular bundle, which carry central vision and have a high energy demand.
- Ethambutol, used for tuberculosis. Toxicity is dose-related: it is uncommon at 15 mg/kg/day or less and frequent at high doses. The drug is cleared by the kidneys, so renal impairment raises the risk. Red-green colour loss is typical, and the chiasm can be affected, giving a bitemporal defect. The BNF asks for visual acuity to be tested on a Snellen chart before treatment and for patients to stop the drug at once and seek advice if vision deteriorates.
- Methanol. It is metabolised to formic acid, which blocks the mitochondrial electron transport chain. After ingestion there is severe metabolic acidosis and sudden bilateral visual loss, often with swollen discs. Treatment is correction of the acidosis with sodium bicarbonate, an antidote that blocks methanol metabolism (ethanol is the traditional one), and haemodialysis in severe cases.
- Vitamin B12 deficiency, from pernicious anaemia, a strict vegan diet without supplements or gut surgery, and deficiency of folate, thiamine or copper. Bariatric surgery is an increasingly recognised cause.
- Tobacco and alcohol. Heavy use is usually combined with poor diet, and the deficiency probably matters more than the toxin.
- Other drugs include linezolid in prolonged courses, isoniazid and amiodarone. Amiodarone differs in causing disc swelling that can resemble NAION.
Hereditary optic neuropathies
Two inherited diseases are examined, and both are disorders of mitochondria in retinal ganglion cells.
Leber hereditary optic neuropathy (LHON) is caused by point mutations in mitochondrial DNA, in genes for complex I of the respiratory chain. Three mutations account for most cases: 11778 (the commonest, about 70% of northern European cases, with the least recovery), 14484 (the best chance of partial recovery) and 3460. Mitochondria come from the egg, so inheritance is maternal: an affected or carrier woman passes the mutation to all her children, and a man passes it to none. Many carriers never lose vision, and men are affected far more often than women, for reasons not fully understood.
The typical patient is a man aged 10 to 30 with painless loss of central vision in one eye, followed weeks to months later by the other. Acuity usually falls below 6/60 with a dense central or caecocentral scotoma. In the acute phase the disc looks red and swollen with fine dilated vessels around it (peripapillary telangiectasia), but fluorescein angiography shows no leakage, so this is pseudo-oedema. Optic atrophy follows. NICE (TA1093, 2025) recommends idebenone as an option for visual impairment in LHON in people aged 12 and over. Carriers are advised not to smoke and to limit alcohol.
Dominant optic atrophy (Kjer type) is the commonest hereditary optic neuropathy. It is autosomal dominant, usually from mutations in the nuclear gene OPA1 on chromosome 3, which encodes a protein of the inner mitochondrial membrane. Loss begins insidiously in the first or second decade of life, is bilateral and roughly symmetrical, and is mild to moderate: more than 80% of patients keep vision better than 6/60. There is a blue-yellow (tritan) colour defect, a central or caecocentral scotoma and temporal pallor of the discs. Severity varies widely within a family.
| Leber hereditary optic neuropathy | Dominant optic atrophy | |
|---|---|---|
| Gene | Mitochondrial DNA (11778, 14484, 3460) | OPA1, nuclear, chromosome 3 |
| Inheritance | Maternal | Autosomal dominant |
| Onset | Age 10 to 30, mostly men | First or second decade |
| Tempo | Subacute, one eye then the other | Insidious, both eyes together |
| Final acuity | Usually worse than 6/60 | Usually better than 6/60 |
| Disc | Acute pseudo-oedema with telangiectasia, then atrophy | Temporal pallor |
Summary
- AION is an infarct of the optic nerve head in the territory of the short posterior ciliary arteries, and the disc is swollen at onset.
- NAION affects a small crowded disc at risk, causes painless loss often noticed on waking with an altitudinal defect, and has no proven treatment.
- Arteritic AION is caused by giant cell arteritis: age 50 or over, headache, jaw claudication, scalp tenderness, a pale swollen disc and raised ESR, CRP and platelets.
- In suspected GCA give high-dose steroid at once: prednisolone 40 to 60 mg daily, or intravenous methylprednisolone first if vision is affected.
- Confirm GCA with temporal artery ultrasound or biopsy, but never delay treatment for the test; a negative biopsy does not exclude it.
- Slowly progressive unilateral visual loss or unexplained optic atrophy needs MRI to exclude compression; optociliary shunt vessels suggest optic nerve sheath meningioma.
- Toxic and nutritional neuropathies are bilateral, symmetrical and painless with caecocentral scotomas and colour loss.
- Ethambutol toxicity is dose-related and worse in renal impairment; test acuity before treatment and stop the drug if vision falls.
- LHON is maternally inherited through mitochondrial DNA (11778 commonest), affects young men sequentially and severely, and idebenone is a NICE-recommended option.
- Dominant optic atrophy is autosomal dominant (OPA1), begins in childhood and causes mild to moderate loss with temporal pallor and a tritan defect.
Check yourself
Quick recall on this lesson. These are easier than the question bank.
Written for revision. It is not a source of clinical advice, and guidance changes.